Title: Differential regulation of tefluthrin and telmisartan on the gating charges of I(Na) activation and inactivation as well as on resurgent and persistent I(Na) in a pituitary cell line (GH(3)).
Journal: Toxicology letters 20180315
Title: Mechanism of As2O3-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20170801
Title: Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine.
Journal: Bioorganic & medicinal chemistry letters 20160701
Title: Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11).
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131201
Title: Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20131201
Title: Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease.
Journal: The American journal of cardiology 20121115
Title: Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchange.
Journal: The Journal of pharmacology and experimental therapeutics 20121101
Title: Antiarrhythmic properties of ranolazine--from bench to bedside.
Journal: Expert opinion on investigational drugs 20121101
Title: Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling.
Journal: Circulation 20121030
Title: Electrophysiological characterization of sodium-activated potassium channels in NG108-15 and NSC-34 motor neuron-like cells.
Journal: Acta physiologica (Oxford, England) 20121001
Title: Effects of ranolazine on exercise tolerance and angina frequency in patients with severe chronic angina receiving maximally-tolerated background therapy: analysis from the Combination Assessment of Ranolazine In Stable Angina (CARISA) randomized trial.
Journal: European journal of preventive cardiology 20121001
Title: Carbon monoxide induces cardiac arrhythmia via induction of the late Na+ current.
Journal: American journal of respiratory and critical care medicine 20121001
Title: [New pharmacological approaches to ischemic heart disease].
Journal: Giornale italiano di cardiologia (2006) 20121001
Title: Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation.
Journal: The American journal of cardiology 20120901
Title: New treatment options for late Na current, arrhythmias, and diastolic dysfunction.
Journal: Current heart failure reports 20120901
Title: Ranolazine-induced severe bladder hypotonia.
Journal: The Annals of pharmacotherapy 20120901
Title: Long-term nerve excitability changes by persistent Na+ current blocker ranolazine.
Journal: Neuroscience letters 20120830
Title: [Involvement of veratridine-induced increase of reverse Na(+)/Ca(2+) exchange current in intracellular Ca(2+) overload and extension of action potential duration in rabbit ventricular myocytes].
Journal: Sheng li xue bao : [Acta physiologica Sinica] 20120825
Title: A novel reverse phase stability indicating RP-UPLC method for the quantitative determination of fifteen related substances in Ranolazine drug substance and drug product.
Journal: Talanta 20120815
Title: Metabolic antianginal agent ranolazine offers good symptom relief in a patient with inoperable severe aortic stenosis.
Journal: Cardiovascular therapeutics 20120801
Title: ATX-II-induced pulmonary vein arrhythmogenesis related to atrial fibrillation and long QT syndrome.
Journal: European journal of clinical investigation 20120801
Title: Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.
Journal: Journal of the American College of Cardiology 20120724
Title: Development and validation of a sensitive U-HPLC-MS/MS method with electrospray ionization for quantitation of ranolazine in human plasma: application to a clinical pharmacokinetic study.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120715
Title: Treating stable angina - is there a NICE way towards an international consensus?
Journal: International journal of clinical practice 20120701
Title: Changes of the peripheral nerve excitability in vivo induced by the persistent Na+ current blocker ranolazine.
Journal: Neuroscience letters 20120614
Title: Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel Na(v)1.5: a novel mechanism of drug action.
Journal: Circulation 20120605
Title: Cardiac sodium channel Na(v)1.5 mechanosensitivity is inhibited by ranolazine.
Journal: Circulation 20120605
Title: Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2.
Journal: Heart rhythm 20120601
Title: Block of Na+ currents and suppression of action potentials in embryonic rat dorsal root ganglion neurons by ranolazine.
Journal: Neuropharmacology 20120601
Title: Costs and clinical outcomes associated with use of ranolazine for treatment of angina.
Journal: Clinical therapeutics 20120601
Title: A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention.
Journal: American heart journal 20120601
Title: Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes.
Journal: Heart (British Cardiac Society) 20120515
Title: Effect of ranolazine on rat intrarenal arteries in vitro.
Journal: European journal of pharmacology 20120515
Title: Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque.
Journal: Heart (British Cardiac Society) 20120501
Title: Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
Journal: Circulation. Arrhythmia and electrophysiology 20120401
Title: Electrophysiological characteristics of canine superior vena cava sleeve preparations: effect of ranolazine.
Journal: Circulation. Arrhythmia and electrophysiology 20120401
Title: [Management of refractory symptoms in hypertrophic cardiomyopathy with restrictive pathophysiology: novel perspectives for ranolazine].
Journal: Giornale italiano di cardiologia (2006) 20120401
Title: [Update coronary artery disease: important progresses in acute and chronic therapy].
Journal: MMW Fortschritte der Medizin 20120322
Title: Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity.
Journal: Circulation research 20120316
Title: Development and validation of a sensitive LC-MS/MS assay for simultaneous quantitation of ranolazine and its three metabolites in human plasma.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120315
Title: Ranolazine safely decreases ventricular and atrial fibrillation in Timothy syndrome (LQT8).
Journal: Pacing and clinical electrophysiology : PACE 20120301
Title: Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
Journal: Heart rhythm 20120301
Title: Comparative pharmacophysiology of vernakalant, ranolazine, and d-sotalol in canine pulmonary vein sleeve preparations: new flavors or same old taste?
Journal: Heart rhythm 20120301
Title: Role of ranolazine in angina, heart failure, arrhythmias, and diabetes.
Journal: Pharmacology & therapeutics 20120301
Title: Damage to mitochondrial complex I during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine.
Journal: Biochimica et biophysica acta 20120301
Title: The use of ranolazine to facilitate electrical cardioversion in cardioversion-resistant patients: a case series.
Journal: Pacing and clinical electrophysiology : PACE 20120301
Title: Second chance for dronedarone after recent setback?
Journal: Lancet (London, England) 20120218
Title: [Conservative therapy of patients with stable coronary heart disease].
Journal: Herz 20120201
Title: Ranolazine for the treatment of refractory angina in a veterans population.
Journal: Cardiovascular revascularization medicine : including molecular interventions 20120101
Title: Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Journal: Journal of molecular medicine (Berlin, Germany) 20120101
Title: Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.
Journal: The Journal of pharmacology and experimental therapeutics 20120101
Title: Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial.
Journal: Clinical chemistry 20120101
Title: Clinical experience with ranolazine in a veteran population with chronic stable angina.
Journal: The Annals of pharmacotherapy 20120101
Title: Is randomization to placebo safe? Risk in placebo-controlled angina trials: angina risk meta-analysis.
Journal: Cardiology 20120101
Title: Ranolazine, tacrolimus, and diltiazem might be a hazardous combination in a transplant patient.
Journal: Renal failure 20120101
Title: [Ranolazine in the treatment of chronic stable angina].
Journal: La Clinica terapeutica 20120101
Title: Validated liquid chromatography mass spectrometry method for quantitative determination of strictosamide in dog plasma and its application to pharmacokinetic study.
Journal: Biomedical chromatography : BMC 20111201
Title: Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Journal: Pacing and clinical electrophysiology : PACE 20111201
Title: Effects of ranolazine on cloned cardiac kv4.3 potassium channels.
Journal: The Journal of pharmacology and experimental therapeutics 20111201
Title: The editor's roundtable: role of percutaneous coronary intervention and drug-eluting stents in patients with stable coronary heart disease.
Journal: The American journal of cardiology 20111115
Title: Metabolic modulation: a new therapeutic target in treatment of heart failure.
Journal: American journal of therapeutics 20111101
Title: Arrhythmogenic left atrial cellular electrophysiology in a murine genetic long QT syndrome model.
Journal: Cardiovascular research 20111001
Title: Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts.
Journal: Pharmacological research 20111001
Title: Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: I. Experimental analysis of the use-dependent block.
Journal: American journal of physiology. Heart and circulatory physiology 20111001
Title: Mechanisms of atrial-selective block of Na⁺ channels by ranolazine: II. Insights from a mathematical model.
Journal: American journal of physiology. Heart and circulatory physiology 20111001
Title: [The late sodium current: pathophysiology and pharmacology of a new therapeutic target].
Journal: Giornale italiano di cardiologia (2006) 20111001
Title: Ranolazine injection into coronary or femoral arteries exerts marked, transient regional vasodilation without systemic hypotension in an intact porcine model.
Journal: Circulation. Cardiovascular interventions 20111001
Title: Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
Journal: British journal of pharmacology 20110901
Title: Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice.
Journal: American journal of physiology. Cell physiology 20110901
Title: Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.
Journal: Toxicological sciences : an official journal of the Society of Toxicology 20110901
Title: Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting.
Journal: The American journal of cardiology 20110901
Title: Effects of ranolazine on cardiovascular system.
Journal: Recent patents on cardiovascular drug discovery 20110901
Title: The antianginal agent ranolazine is a potent antiarrhythmic agent that reduces ventricular arrhythmias: through a mechanism favoring inhibition of late sodium channel.
Journal: Cardiovascular therapeutics 20110801
Title: Electrophysiologic basis for the antiarrhythmic actions of ranolazine.
Journal: Heart rhythm 20110801
Title: Ranolazine: Déjà vu of the amiodarone story.
Journal: Heart rhythm 20110801
Title: Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
Journal: The American journal of medicine 20110801
Title: Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations.
Journal: European journal of pharmacology 20110715
Title: Ranolazine for the treatment of heart failure with preserved ejection fraction: background, aims, and design of the RALI-DHF study.
Journal: Clinical cardiology 20110701
Title: [New agents for the therapy of angina pectoris].
Journal: Der Internist 20110701
Title: Ranolazine: an antianginal drug with antiarrhythmic properties.
Journal: Expert review of cardiovascular therapy 20110701
Title: Improvement in left ventricular systolic and diastolic performance during ranolazine treatment in patients with stable angina.
Journal: Journal of cardiovascular pharmacology and therapeutics 20110601
Title: First direct comparison of the late sodium current blocker ranolazine to established antiarrhythmic agents in an ischemia/reperfusion model.
Journal: Journal of cardiovascular pharmacology and therapeutics 20110601
Title: Antiadrenergic and hemodynamic effects of ranolazine in conscious dogs.
Journal: Journal of cardiovascular pharmacology 20110601
Title: Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain.
Journal: The Journal of pharmacology and experimental therapeutics 20110501
Title: The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality.
Journal: Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 20110501
Title: Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.
Journal: JACC. Cardiovascular imaging 20110501
Title: Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.
Journal: Circulation 20110426
Title: Letter by Madias regarding article, 'Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial'.
Journal: Circulation 20110412
Title: Letter by Ayalloore and LeLorier regarding article, 'Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial'.
Journal: Circulation 20110412
Title: Antifibrillatory effect of ranolazine during severe coronary stenosis in the intact porcine model.
Journal: Heart rhythm 20110401
Title: Ranolazine increases β-cell survival and improves glucose homeostasis in low-dose streptozotocin-induced diabetes in mice.
Journal: The Journal of pharmacology and experimental therapeutics 20110401
Title: Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine.
Journal: Journal of the American College of Cardiology 20110118
Title: Electrophysiological properties of HBI-3000: a new antiarrhythmic agent with multiple-channel blocking properties in human ventricular myocytes.
Journal: Journal of cardiovascular pharmacology 20110101
Title: Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling.
Journal: Journal of molecular and cellular cardiology 20110101
Title: Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels.
Journal: American journal of physiology. Heart and circulatory physiology 20110101
Title: Ranolazine block of human Na v 1.4 sodium channels and paramyotonia congenita mutants.
Journal: Channels (Austin, Tex.) 20110101
Title: Extended-release ranolazine: critical evaluation of its use in stable angina.
Journal: Vascular health and risk management 20110101
Title: The electrophysiological properties of ranolazine: a metabolic anti-ischemic drug or an energy-efficient antiarrhythmic agent?
Journal: Reviews in cardiovascular medicine 20110101
Title: Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
Journal: Pacing and clinical electrophysiology : PACE 20101201
Title: Effects of ranolazine on fatty acid transformation in the isolated perfused rat liver.
Journal: Molecular and cellular biochemistry 20101201
Title: Perspective: does ranolazine have potential for the treatment of atrial fibrillation?
Journal: Expert opinion on investigational drugs 20101201
Title: [New developments in the antiarrhythmic therapy of atrial fibrillation].
Journal: Herzschrittmachertherapie & Elektrophysiologie 20101201
Title: Ranolazine selectively blocks persistent current evoked by epilepsy-associated Naν1.1 mutations.
Journal: British journal of pharmacology 20101101
Title: Ranolazine-tacrolimus interaction.
Journal: The Annals of pharmacotherapy 20101101
Title: Rhabdomyolysis in a patient receiving ranolazine and simvastatin.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20101101
Title: Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.
Journal: Journal of the American College of Cardiology 20101005
Title: [Ranolazine--an additional anti-anginal drug].
Journal: Deutsche medizinische Wochenschrift (1946) 20101001
Title: The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease.
Journal: Journal of the American College of Cardiology 20100914
Title: Ranolazine and its anti-ischemic effects: revisiting an old mechanistic paradigm anew?
Journal: Journal of the American College of Cardiology 20100914
Title: [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
Journal: Yao xue xue bao = Acta pharmaceutica Sinica 20100901
Title: Ranolazine is effective for acute or chronic ischemic dysfunction with heart failure.
Journal: Journal of the American College of Cardiology 20100831
Title: The riddle of nonsustained ventricular tachycardia and sudden cardiac death: are we approaching a solution?
Journal: Circulation 20100803
Title: Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Journal: Circulation 20100803
Title: Autophagy induced by ischemic preconditioning is essential for cardioprotection.
Journal: Journal of cardiovascular translational research 20100801
Title: Conventional and novel drug therapeutics to relief myocardial ischemia.
Journal: Cardiovascular drugs and therapy 20100801
Title: Late sodium current contributes to diastolic cell Ca2+ accumulation in chronic heart failure.
Journal: The journal of physiological sciences : JPS 20100701
Title: Modulation of myocardial metabolism: an emerging therapeutic principle.
Journal: Current opinion in cardiology 20100701
Title: Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps my angina. Do you have any suggestions for my heart since I no longer make testosterone, which I understand helps protect men's hearts and arteries.
Journal: Harvard heart letter : from Harvard Medical School 20100701
Title: Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome.
Journal: Diabetes care 20100601
Title: Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium.
Journal: Journal of the American College of Cardiology 20100525
Title: Enhanced late na(+) currents in atrial fibrillation new drug target or just an epiphenomenon?
Journal: Journal of the American College of Cardiology 20100525
Title: Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I.
Journal: Journal of the American College of Cardiology 20100511
Title: Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36).
Journal: Circulation 20100427
Title: New antiarrhythmic drugs for treatment of atrial fibrillation.
Journal: Lancet (London, England) 20100403
Title: Ranolazine (Ranexa) in the treatment of chronic stable angina.
Journal: Advances in therapy 20100401
Title: B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial.
Journal: Journal of the American College of Cardiology 20100323
Title: Biomarker bonanza?
Journal: Journal of the American College of Cardiology 20100323
Title: Intrapericardial ranolazine prolongs atrial refractory period and markedly reduces atrial fibrillation inducibility in the intact porcine heart.
Journal: Journal of cardiovascular pharmacology 20100301
Title: Ranolazine: an anti-anginal drug with further therapeutic potential.
Journal: Expert review of cardiovascular therapy 20100301
Title: Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model.
Journal: Journal of the American College of Cardiology 20100223
Title: Synergistic electrophysiologic and antiarrhythmic effects of the combination of ranolazine and chronic amiodarone in canine atria.
Journal: Circulation. Arrhythmia and electrophysiology 20100201
Title: Ranolazine-related dyspnea on exertion.
Journal: The American journal of geriatric pharmacotherapy 20100201
Title: Ranolazine attenuation of CFA-induced mechanical hyperalgesia.
Journal: Pain medicine (Malden, Mass.) 20100101
Title: Chick embryo partial ischemia model: a new approach to study ischemia ex vivo.
Journal: PloS one 20100101
Title: Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability.
Journal: Molecular pain 20100101
Title: Ranolazine: a new approach to treating an old problem.
Journal: Texas Heart Institute journal 20100101
Title: At the dawn of a new era in treating angina pectoris, or just another antianginal drug? Some considerations about ranolazine.
Journal: Romanian journal of internal medicine = Revue roumaine de medecine interne 20100101
Title: [Ranolazine--new treatment of chronic stable angina pectoris].
Journal: Ugeskrift for laeger 20091207
Title: Ranolazine attenuates behavioral signs of neuropathic pain.
Journal: Behavioural pharmacology 20091201
Title: Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart.
Journal: The Journal of pharmacology and experimental therapeutics 20091101
Title: Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion.
Journal: American journal of physiology. Heart and circulatory physiology 20091101
Title: Use-dependent block of cardiac late Na(+) current by ranolazine.
Journal: Heart rhythm 20091101
Title: Synthesis of ranolazine metabolites and their anti-myocardial ischemia activities.
Journal: Chemical & pharmaceutical bulletin 20091101
Title: A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.
Journal: JACC. Cardiovascular imaging 20091101
Title: Ranolazine and the myocardial demand-supply balance.
Journal: JACC. Cardiovascular imaging 20091101
Title: A novel mechanism for the treatment of angina, arrhythmias, and diastolic dysfunction: inhibition of late I(Na) using ranolazine.
Journal: Journal of cardiovascular pharmacology 20091001
Title: A slowly inactivating sodium current contributes to spontaneous diastolic depolarization of atrial myocytes.
Journal: American journal of physiology. Heart and circulatory physiology 20091001
Title: Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Journal: Nature chemical biology 20091001
Title: New pharmacological agents for arrhythmias.
Journal: Circulation. Arrhythmia and electrophysiology 20091001
Title: Suppression of non-sustained ventricular tachycardia with ranolazine: a case report.
Journal: WMJ : official publication of the State Medical Society of Wisconsin 20091001
Title: Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts.
Journal: Circulation 20090915
Title: Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart.
Journal: American journal of physiology. Heart and circulatory physiology 20090901
Title: Chronic angina and the treatment with ranolazine: facts and recommendations.
Journal: Progress in cardiovascular nursing 20090901
Title: Analytical studies of rapidly inactivating and noninactivating sodium currents in differentiated NG108-15 neuronal cells.
Journal: Journal of theoretical biology 20090821
Title: Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine.
Journal: Journal of molecular and cellular cardiology 20090801
Title: The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Journal: The Journal of pharmacology and experimental therapeutics 20090801
Title: Ranolazine improves endothelial function in patients with stable coronary artery disease.
Journal: Coronary artery disease 20090801
Title: Ranolazine: new drug. Stable angina: not worth the risk.
Journal: Prescrire international 20090801
Title: Ranolazine exerts potent effects on atrial electrical properties and abbreviates atrial fibrillation duration in the intact porcine heart.
Journal: Journal of cardiovascular electrophysiology 20090701
Title: Effects of ranolazine, a novel anti-anginal drug, on ion currents and membrane potential in pituitary tumor GH(3) cells and NG108-15 neuronal cells.
Journal: Journal of pharmacological sciences 20090701
Title: Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.
Journal: Circulation. Cardiovascular quality and outcomes 20090701
Title: Ranolazine as an adjunct to cardioplegia: a potential new therapeutic application.
Journal: Journal of cardiovascular pharmacology and therapeutics 20090601
Title: Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial.
Journal: Journal of the American College of Cardiology 20090428
Title: Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial.
Journal: Circulation 20090421
Title: Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
Journal: Journal of the American College of Cardiology 20090421
Title: Direct toxic effects of aqueous extract of cigarette smoke on cardiac myocytes at clinically relevant concentrations.
Journal: Toxicology and applied pharmacology 20090401
Title: Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance.
Journal: American journal of physiology. Heart and circulatory physiology 20090301
Title: The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Journal: Current pharmaceutical design 20090101
Title: [Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
Journal: Giornale italiano di cardiologia (2006) 20090101
Title: Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.
Journal: Journal of electrocardiology 20090101
Title: The antiarrhythmic effects of ranolazine.
Journal: Reviews in cardiovascular medicine 20090101
Title: Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation.
Journal: Reviews in cardiovascular medicine 20090101
Title: Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study.
Journal: Journal of pharmaceutical and biomedical analysis 20081215
Title: Use of ranolazine in long-QT syndrome type 3.
Journal: Journal of cardiovascular electrophysiology 20081201
Title: Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.
Journal: Journal of cardiovascular electrophysiology 20081201
Title: Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.
Journal: American journal of physiology. Heart and circulatory physiology 20081101
Title: Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias.
Journal: Cardiology clinics 20081101
Title: Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
Journal: Circulation. Cardiovascular quality and outcomes 20081101
Title: Ranolazine for chronic stable angina.
Journal: Lancet (London, England) 20081011
Title: Effect of ranolazine on ventricular vulnerability and defibrillation threshold in the intact porcine heart.
Journal: Journal of cardiovascular electrophysiology 20081001
Title: The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
Journal: Journal of cardiovascular pharmacology and therapeutics 20080901
Title: Pathophysiology and pharmacology of the cardiac 'late sodium current.'.
Journal: Pharmacology & therapeutics 20080901
Title: Chronic stable angina pectoris.
Journal: Disease-a-month : DM 20080901
Title: Determination of ranolazine in human plasma by liquid chromatographic-tandem mass spectrometric assay.
Journal: Journal of chromatographic science 20080901
Title: Utility of ranolazine in chronic stable angina patients.
Journal: Vascular health and risk management 20080801
Title: Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Journal: Journal of molecular and cellular cardiology 20080701
Title: Another calcium paradox in heart failure.
Journal: Journal of molecular and cellular cardiology 20080701
Title: Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations.
Journal: Heart rhythm 20080701
Title: Chasing with ranolazine pulmonary vein afterpotentials before it's too late.
Journal: Heart rhythm 20080701
Title: The evolving role of medical therapy for chronic stable angina.
Journal: Current cardiology reports 20080701
Title: Expanding the understanding of the treatment of chronic angina: a 21st century approach-part II.
Journal: Clinical cardiology 20080701
Title: Metabolic agents in the management of diabetic coronary patients: a new era.
Journal: International journal of cardiology 20080623
Title: Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
Journal: The Journal of pharmacology and experimental therapeutics 20080601
Title: Late sodium current inhibition as a new cardioprotective approach.
Journal: Journal of molecular and cellular cardiology 20080601
Title: Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report.
Journal: Pacing and clinical electrophysiology : PACE 20080601
Title: Rapid kinetic interactions of ranolazine with HERG K+ current.
Journal: Journal of cardiovascular pharmacology 20080601
Title: Expanding the understanding of the treatment of chronic angina: a 21st century approach--part 1.
Journal: Clinical cardiology 20080601
Title: An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes.
Journal: American journal of physiology. Heart and circulatory physiology 20080501
Title: Is ranolazine an antiarrhythmic drug?
Journal: American journal of physiology. Heart and circulatory physiology 20080501
Title: Ranolazine inhibits an oxidative stress-induced increase in myocyte sodium and calcium loading during simulated-demand ischemia.
Journal: Journal of cardiovascular pharmacology 20080501
Title: Mechanism of action of the new anti-ischemia drug ranolazine.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society 20080401
Title: What's new in clinical pharmacology and therapeutics.
Journal: WMJ : official publication of the State Medical Society of Wisconsin 20080401
Title: Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardium.
Journal: British journal of pharmacology 20080301
Title: The cardiac persistent sodium current: an appealing therapeutic target?
Journal: British journal of pharmacology 20080301
Title: State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
Journal: Molecular pharmacology 20080301
Title: Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
Journal: Annals of the New York Academy of Sciences 20080301
Title: Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Journal: Expert review of cardiovascular therapy 20080101
Title: [Determination of residual solvents in ranolazine by headspace gas chromatography].
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20080101
Title: Ranolazine: a review of its use in chronic stable angina pectoris.
Journal: Drugs 20080101
Title: Block of tetrodotoxin-sensitive, Na(V)1.7 and tetrodotoxin-resistant, Na(V)1.8, Na+ channels by ranolazine.
Journal: Channels (Austin, Tex.) 20080101
Title: Multiple drug interactions in a renal transplant patient leading to simvastatin-induced rhabdomyolysis: a case report.
Journal: Medscape journal of medicine 20080101
Title: Sinus node dysfunction in ATX-II-induced in-vitro murine model of long QT3 syndrome and rescue effect of ranolazine.
Journal: Progress in biophysics and molecular biology 20080101
Title: Management of chronic stable angina pectoris.
Journal: Boletin de la Asociacion Medica de Puerto Rico 20080101
Title: Ranolazine: a new option in the management of chronic stable angina.
Journal: Pharmacotherapy 20071201
Title: Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non ST-segment elevation acute coronary syndrome: results from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non ST-Elevation Acute Coronary Syndrome Thrombolysis in Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial.
Journal: Circulation 20071009
Title: The year in non-ST-segment elevation acute coronary syndrome.
Journal: Journal of the American College of Cardiology 20071002
Title: Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine.
Journal: Circulation 20070925
Title: Ranolazine in patients with coronary artery disease.
Journal: Expert opinion on pharmacotherapy 20070901
Title: Ranolazine--a nicely timed new medical therapy for stable angina.
Journal: International journal of clinical practice 20070701
Title: Ranolazine in patients with angina and coronary artery disease.
Journal: Current cardiology reports 20070701
Title: Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazine.
Journal: Heart rhythm 20070501
Title: Ranolazine: a novel agent that improves dysfunctional sodium channels.
Journal: International journal of clinical practice 20070501
Title: Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.
Journal: JAMA 20070425
Title: Does ranolazine have a place in the treatment of acute coronary syndromes?
Journal: JAMA 20070425
Title: A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Journal: The Journal of pharmacology and experimental therapeutics 20070401
Title: New options help angina patients live more active lives. Treating the underlying disease may help you live longer, too.
Journal: Heart advisor 20070401
Title: Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE).
Journal: Journal of the American College of Cardiology 20070313
Title: Sensitive quantification of ranolazine in human plasma by liquid chromatography--tandem mass spectrometry with positive electrospray ionization.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070201
Title: Drug approvals.
Journal: The Nurse practitioner 20070201
Title: New drugs 07, part I.
Journal: Nursing 20070201
Title: Trials and tribulations associated with angina and traditional therapeutic approaches.
Journal: Clinical cardiology 20070201
Title: Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
Journal: Clinical cardiology 20070201
Title: Gender comparison of efficacy and safety of ranolazine for chronic angina pectoris in four randomized clinical trials.
Journal: The American journal of cardiology 20070101
Title: Safety and efficacy of extended-release ranolazine in patients aged 70 years or older with chronic stable angina pectoris.
Journal: The American journal of geriatric cardiology 20070101
Title: Ranolazine, a partial fatty acid oxidation inhibitor, its potential benefit in angina and other cardiovascular disorders.
Journal: Recent patents on cardiovascular drug discovery 20070101
Title: Ranolazine: a novel therapeutic option in chronic stable angina.
Journal: Kathmandu University medical journal (KUMJ) 20070101
Title: Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.
Journal: Journal of molecular and cellular cardiology 20061201
Title: Ranolazine in the management of chronic stable angina.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061201
Title: A pilot study of ranolazine in patients with intermittent claudication.
Journal: International angiology : a journal of the International Union of Angiology 20061201
Title: Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Journal: Journal of cardiovascular pharmacology and therapeutics 20061201
Title: Ranolazine for the management of coronary artery disease.
Journal: Clinical therapeutics 20061201
Title: Inherited long QT syndrome: phenotype and therapy to use and avoid.
Journal: Clinical cardiology 20061001
Title: Modification of myocardial substrate use as a therapy for heart failure.
Journal: Nature clinical practice. Cardiovascular medicine 20060901
Title: Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Journal: Journal of the American College of Cardiology 20060801
Title: Ranolazine: augmenting the antianginal armamentarium.
Journal: Journal of the American College of Cardiology 20060801
Title: Ranolazine, a novel anti-anginal agent, does not alter isosorbide dinitrate- or sildenafil-induced changes in blood pressure in conscious dogs.
Journal: European journal of pharmacology 20060717
Title: Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel.
Journal: The Journal of pharmacology and experimental therapeutics 20060701
Title: Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.
Journal: Heart (British Cardiac Society) 20060701
Title: Treatment options for refractory angina in patients who are not candidates for revascularization.
Journal: Current cardiology reports 20060701
Title: Mechanism of action of ranolazine.
Journal: Archives of internal medicine 20060626
Title: Ranolazine (ranexa) for chronic angina.
Journal: The Medical letter on drugs and therapeutics 20060605
Title: Metabolic therapeutics in angina pectoris: history revisited with perhexiline.
Journal: European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 20060601
Title: Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial.
Journal: American heart journal 20060601
Title: Ranolazine.
Journal: Nature reviews. Drug discovery 20060601
Title: New angina medication approved.
Journal: Health news (Waltham, Mass.) 20060601
Title: Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions.
Journal: Circulation 20060523
Title: Ranolazine and late cardiac sodium current--a therapeutic target for angina, arrhythmia and more?
Journal: British journal of pharmacology 20060501
Title: Molecular basis of ranolazine block of LQT-3 mutant sodium channels: evidence for site of action.
Journal: British journal of pharmacology 20060501
Title: Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current.
Journal: Journal of cardiovascular electrophysiology 20060501
Title: Applying science to drug discovery.
Journal: Biochemical Society transactions 20060401
Title: Ranolazine: a new approach to management of patients with angina.
Journal: The Annals of pharmacotherapy 20060401
Title: Inhibition of sodium-dependent calcium overload to treat myocardial ischemia.
Journal: Clinical cardiology 20060401
Title: FDA okays new drug for tough-to-treat chest pain.
Journal: Harvard heart letter : from Harvard Medical School 20060401
Title: Ranolazine: focusing on angina pectoris.
Journal: Drugs of today (Barcelona, Spain : 1998) 20060301
Title: Evolving treatment strategies for chronic refractory angina.
Journal: Expert opinion on pharmacotherapy 20060201
Title: Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes.
Journal: European heart journal 20060101
Title: Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes.
Journal: European heart journal 20060101
Title: Simple, sensitive and rapid liquid chromatography/atmospheric pressure chemical ionization mass spectrometric method for the quantitation of Ranolazine in rat plasma.
Journal: Rapid communications in mass spectrometry : RCM 20060101
Title: Analytical and semipreparative resolution of ranolazine enantiomers by liquid chromatography using polysaccharide chiral stationary phases.
Journal: Journal of separation science 20060101
Title: Ranolazine, a novel agent for chronic stable angina.
Journal: Pharmacotherapy 20060101
Title: Ranolazine: a review of its use in chronic stable angina pectoris.
Journal: Drugs 20060101
Title: Clinical pharmacokinetics of ranolazine.
Journal: Clinical pharmacokinetics 20060101
Title: New drugs: lubiprostone, ranolazine, and anidulafungin.
Journal: Journal of the American Pharmacists Association : JAPhA 20060101
Title: New treatment for chest pain.
Journal: FDA consumer 20060101
Title: Spotlight on ranolazine in chronic stable angina pectoris.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20060101
Title: Metabolic modulators for chronic cardiac ischemia.
Journal: Journal of cardiovascular pharmacology and therapeutics 20051201
Title: Chronic stable angina.
Journal: The New England journal of medicine 20051006
Title: New drugs for prevention, relief. How you might benefit if 3 medications win FDA approval.
Journal: Heart advisor 20051001
Title: Effect of renal impairment on multiple-dose pharmacokinetics of extended-release ranolazine.
Journal: Clinical pharmacology and therapeutics 20050901
Title: Ranolazine: new approach for the treatment of stable angina pectoris.
Journal: Expert review of cardiovascular therapy 20050901
Title: Combination pharmacologic therapies for heart failure: what next after angiotensin-converting enzyme inhibitors and beta-blockers?
Journal: Current heart failure reports 20050801
Title: Effect of hepatic impairment on the multiple-dose pharmacokinetics of ranolazine sustained-release tablets.
Journal: Journal of clinical pharmacology 20050701
Title: Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects.
Journal: Journal of clinical pharmacology 20050401
Title: The degree of potassium channel blockade and the risk of torsade de pointes: the truth, nothing but the truth, but not the whole truth.
Journal: European heart journal 20050301
Title: Ranolazine CV Therapeutics.
Journal: Current opinion in investigational drugs (London, England : 2000) 20050301
Title: Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Journal: The American journal of cardiology 20050201
Title: Ranolazine. A metabolic modulator for the treatment of chronic stable angina.
Journal: Cardiology in review 20050101
Title: Medical management of myocardial ischemia.
Journal: The American journal of geriatric cardiology 20050101
Title: Chronic angina: new medical options for treatment.
Journal: Reviews in cardiovascular medicine 20050101
Title: Myocardial metabolism: a new target for the treatment of heart disease?
Journal: Current hypertension reports 20041201
Title: Efficacy and safety of a metabolic modulator drug in chronic stable angina: review of evidence from clinical trials.
Journal: Journal of cardiovascular pharmacology and therapeutics 20040901
Title: Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent.
Journal: Journal of cardiovascular pharmacology and therapeutics 20040901
Title: Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.
Journal: Circulation 20040824
Title: Cardiac metabolism as a target for the treatment of heart failure.
Journal: Circulation 20040824
Title: Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome.
Journal: The Journal of pharmacology and experimental therapeutics 20040801
Title: Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes.
Journal: Journal of cardiovascular pharmacology 20040801
Title: Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects.
Journal: British journal of pharmacology 20040801
Title: Ischemic heart disease: metabolic approaches to management.
Journal: Clinical cardiology 20040801
Title: The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice.
Journal: Cancer letters 20040625
Title: Ranolazine as add-on therapy for patients with severe chronic angina.
Journal: JAMA 20040428
Title: Ranolazine as add-on therapy for patients with severe chronic angina.
Journal: JAMA 20040428
Title: Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina.
Journal: Journal of the American College of Cardiology 20040421
Title: Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
Journal: European heart journal 20040401
Title: Companies facing ethical issue as drugs are tested overseas.
Journal: The New York times on the Web 20040305
Title: FDA evaluating new angina drug.
Journal: Health news (Waltham, Mass.) 20040301
Title: Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Journal: JAMA 20040121
Title: Ranolazine and other antianginal therapies in the era of the drug-eluting stent.
Journal: JAMA 20040121
Title: Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD.
Journal: Circulation 20040120
Title: A shift in myocardial substrate, improved endothelial function, and diminished sympathetic activity may contribute to the anti-anginal impact of very-low-fat diets.
Journal: Medical hypotheses 20040101
Title: Effects of very low-fat diets on anginal symptoms.
Journal: Medical hypotheses 20040101
Title: Common cardiac conditions in the elderly are still not well understood.
Journal: The American journal of geriatric cardiology 20040101
Title: [Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. Results of CARISA].
Journal: Kardiologiia 20040101
Title: [Regulation of myocardial metabolism: possibilities and application in cardiac surgery].
Journal: Kardiologia polska 20031201
Title: The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
Journal: Circulation research 20030808
Title: Partial fatty acid oxidation (pFOX) inhibition: a new therapy for chronic stable angina.
Journal: Clinical cardiology 20030401
Title: Metabolic modulation and optimization of energy consumption in heart failure.
Journal: The Medical clinics of North America 20030301
Title: Gender difference in ranolazine pharmacokinetics in rats.
Journal: European journal of drug metabolism and pharmacokinetics 20030101
Title: Molecule of the month: ranolazine.
Journal: Drug news & perspectives 20030101
Title: Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor.
Journal: Current problems in cardiology 20021201
Title: Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure.
Journal: Journal of cardiac failure 20021201
Title: The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.
Journal: Herz 20021101
Title: Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure.
Journal: Circulation research 20020823
Title: Partial fatty acid oxidation inhibitors for stable angina.
Journal: Expert opinion on investigational drugs 20020501
Title: Anti-angina drug shifts heart muscle's fuel use. Compelling the heart to burn more blood sugar and less fat appears to boost cardiac efficiency.
Journal: Heart advisor 20020401
Title: New angina drugs on the horizon?
Journal: Harvard heart letter : from Harvard Medical School 20020201
Title: The use of ranolazine in cardiovascular disease.
Journal: Expert opinion on investigational drugs 20020101
Title: Clinical trials update: The Heart Protection Study, IONA, CARISA, ENRICHD, ACUTE, ALIVE, MADIT II and REMATCH. Impact Of Nicorandil on Angina. Combination Assessment of Ranolazine In Stable Angina. ENhancing Recovery In Coronary Heart Disease patients. Assessment of Cardioversion Using Transoesophageal Echocardiography. AzimiLide post-Infarct surVival Evaluation. Randomised Evaluation of Mechanical Assistance for Treatment of Chronic Heart failure.
Journal: European journal of heart failure 20020101
Title: Cardiovascular news.
Journal: Circulation 20011127
Title: Mitochondria as target for antiischemic drugs.
Journal: Advanced drug delivery reviews 20010702
Title: Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.
Journal: European journal of pharmacology 20010420
Title: Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular system.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20010401
Title: Ranolazine: a potential new treatment for chronic stable angina.
Journal: Heart disease (Hagerstown, Md.) 20010101
Title: Role of metabolically active drugs in the management of ischemic heart disease.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20010101
Title: Keating GM. Ranolazine: A Review of Its Use as Add-On Therapy in Patients with Chronic Stable Angina Pectoris. Drugs. 2013 Jan;73(1):55-73.
Title: Wang WQ, Robertson C, Dhalla AK, Belardinelli L. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4-hydroxy-3-(2-methoxyphenoxy)propyl-1-piperazine (ranolazine) in anesthetized rabbits. J Pharmacol Exp Ther. 2008 Jun;325(3):875-81. doi: 10.1124/jpet.108.137729. Epub 2008 Mar 5.
Title: Zacharowski K, Blackburn B, Thiemermann C. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol. 2001 Apr 20;418(1-2):105-10.
